Targeted imaging of lung cancer with hyperpolarized 129xe mri using surface-modified iron oxide nanoparticles as molecular contrast agents

HIGHLIGHTS

• who: Atsuomi Kimura and collaborators from the Department of Medical Physics and Engineering, Area of Medical Imaging Technology and Science, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan have published the research work: Targeted Imaging of Lung Cancer with Hyperpolarized 129Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of /2022/
• what: The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP 129 Xe MRI nanoparticles (IONPs) as molecular targeting . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.